Absolute Return Capital’s Bio-Techne TECH Stock Holding History

Absolute Return Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-139,000	Closed	-$2.97M	–	1370
2014 Q1	$2.97M	Buy	139,000 +73,164	+111%	+$1.65M	0.04%	420
2013 Q4	$1.56M	Buy	65,836 +34,596	+111%	+$750K	0.02%	554
2013 Q3	$625K	Sell	31,240 -125,712	-80%	-$2.39M	0.01%	583
2013 Q2	$2.71M	Buy	+156,952	New	+$2.61M	0.03%	487

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Absolute Return Capital's TECH Position: Q2 2014 in Review

Absolute Return Capital sold out of Bio-Techne (TECH) in Q2 2014, closing a stake of 139,000 shares — an estimated $2.97M sold.

Absolute Return Capital first reported a position in TECH in Q2 2013 and held it in 4 quarters. The position peaked at $2.97M in Q1 2014. 237 funds tracked by Wall St. Rank hold TECH as of Q2 2014.

Absolute Return Capital reported no remaining Bio-Techne position as of Q2 2014 after selling out during the quarter.
Absolute Return Capital sold 139,000 Bio-Techne shares in Q2 2014, an estimated $2.97M.
Absolute Return Capital first reported a position in Bio-Techne in Q2 2013 and held it in 4 quarters.
Absolute Return Capital's Bio-Techne position peaked at $2.97M in Q1 2014.
237 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2014.

Based on Absolute Return Capital's 13F filing for Q2 2014, filed 14 Aug 2014.